KLK11 and cancer: With KLK11 down-regulated by −7.37× in “A”, −57.82× in “B” and −27.11× in “C”, our study confirmed previous reports e.g., [100], of this gene down-regulation in cancer regions with respect to the surrounding benign tissue in prostate tumors.